EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIV-1 APOBEC-context Mutations Detected by Next-Generation Sequencing in Plasma: Implications for Drug Resistance Interpretation

Marta Illescas-López iD, Paloma Muñoz Báez iD, Adolfo de Salazar iD, Rafael Delgado iD, Asunción Iborra, Juan Carlos Galán, Raquel Carracedo iD, Mayra Sigcha, Carla López-Causape, Ana Fuentes iD, Antonio Aguilera iD, Cristina Marco-Sánchez und 2 weitere

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Marta Illescas-López und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario de San Cecilio de Granada, Instituto de Investigación Ibs.Granada, Ciber de Enfermedades Infecciosas Ciberinfec, Madrid, Spain. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Mutation, Drug Resistance, Viral. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo de Investigación Sanitaria, CIBER, onsorcio Centro de Investigación Biomédica en Red.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

APOBEC3-mediated cytidine deamination produces G→A substitutions in HIV genomes, described in proviral DNA but detectable in plasma HIV-1 RNA using NGS. APOBEC-signature mutations reflect G→A enrichment substitutions, whereas APOBEC-context mutations are substitutions at drug resistance-associated positions compatible with APOBEC editing. We evaluated theirprevalence and impact on resistance interpretation.

Methods

We retrospectively analysed plasma HIV-1 NGS-sequences from antiretroviral-naive individuals in 2022–2023. Sequencing was performed in participating laboratories, and FASTQ centrally reanalyzed using DeepChek. APOBEC-signature mutations, APOBEC-context drug resistance mutations (DRMs), and stop codons were assessed in protease, reverse transcriptase, and integrase at 1%, 3%, and 5% thesholds.

Results

Among 290 individuals, 268 had complete NGS. At 1%, APOBEC-signature mutations were detected in 159 individuals and APOBEC-context DRMs in 64 (22%). Both patterns coexisted in 52 (18%), decreasing to 17 (6%) and 8 (3%) at 3% and 5% thresholds. Certain mutations, including M184I, G190E, G140S, and R263K, remained detectable at higher thresholds. R263K co-occurred with multiple APOBEC-signature mutations and stop codons indicating extensive APOBEC-mediated editing.

Conclusions

APOBEC-associated mutations are detectable in plasma HIV-1 RNA and may affect resistance interpretation. Conservative frequency thresholds (5%) APOBEC-signatures evaluation may reduce misclassification of APOBEC-induced variants as clinically relevant resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsMutationDrug Resistance, ViralAPOBEC DeaminasesHumansHigh-Throughput Nucleotide SequencingRetrospective StudiesRNA, Viral

Stichwörter der Autor:innen

APOBECHIV-1NGS-Genotypingintegraseresistance

Substanzen

APOBEC DeaminasesRNA, Viral

Autor:innen und Institutionen

  • Hospital Universitario de San Cecilio de Granada, Instituto de Investigación Ibs.Granada, Ciber de Enfermedades Infecciosas Ciberinfec, Madrid, Spain.
  • Hospital Universitario 12 de Octubre, Madrid, Ciber de Enfermedades Infecciosas Ciberinfec, Madrid, Spain.
  • Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Hospital Ramón y Cajal, Madrid, Ciber de Epidemiología y Salud Pública, Madrid, Spain.
  • Departamento de Microbiologia, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Departamento de Microbiologia, Hospital Universitario Son Espases, Palma de Mallorca.

ORCID-Profile: Marta Illescas-López, Paloma Muñoz Báez, Adolfo de Salazar, Rafael Delgado, Raquel Carracedo, Ana Fuentes, Antonio Aguilera, Federico García

Förderung

  • Fondo de Investigación Sanitaria
  • CIBER
  • onsorcio Centro de Investigación Biomédica en Red
  • Ministerio de Ciencia e Innovación
  • NextGenerationEU
  • Instituto de Salud Carlos III

Zitieren

APA

Illescas-López, M., Muñoz Báez, P., de Salazar, A., Delgado, R., Iborra, A., Galán, J. C., Carracedo, R., Sigcha, M., López-Causape, C., Fuentes, A., Aguilera, A., Marco-Sánchez, C., García, F., & CoRIS (2026). HIV-1 APOBEC-context Mutations Detected by Next-Generation Sequencing in Plasma: Implications for Drug Resistance Interpretation. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag277

Vancouver

Illescas-López M, Muñoz Báez P, de Salazar A, Delgado R, Iborra A, Galán JC, et al. HIV-1 APOBEC-context Mutations Detected by Next-Generation Sequencing in Plasma: Implications for Drug Resistance Interpretation. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag277

BibTeX
@article{IllescasLpez2026,
  author = {Illescas-López, Marta and Muñoz Báez, Paloma and de Salazar, Adolfo and Delgado, Rafael and Iborra, Asunción and Galán, Juan Carlos and Carracedo, Raquel and Sigcha, Mayra and López-Causape, Carla and Fuentes, Ana and Aguilera, Antonio and Marco-Sánchez, Cristina and García, Federico and CoRIS, CoRIS},
  title = {HIV-1 APOBEC-context Mutations Detected by Next-Generation Sequencing in Plasma: Implications for Drug Resistance Interpretation},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag277}
}
Kostenlos starten →